- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07542977
Individual Neurophysiological Sensory Profiles in People With and Without Neurodevelopmental Disorders (SensAUry)
The goal of this observational study is to evaluate intra-individual neurophysiological variability in children and adults with and without NeuroDevelopmental Disorders (NDD), for several sensory modalities and types of stimulation. The main hypotheses are:
- NDD participants and children exhibit higher intra-individual variability than other participants
- intra-individual neurophysiological variability is correlated to behavioral, psychological and learning profiles
Participants in this study will:
- be recorded for EEG and other neurophysiological parameters while exposed to sensory stimulations, to quantify sensory neurophysiological variability
- perform behavioral tests and fill out questionnaires, to establish the behavioral and psychological profile
- train for perceptual learning, to measure learning abilities
These evaluations will be split in 3 visits spread on a maximum of 3 months, and training for learning will be done at home in between 2 visits.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Adeline MOUSSET
- Phone Number: 0218370645
- Email: a.fourmy@chu-tours.fr
Study Contact Backup
- Name: Claire WARDAK, Dr
- Phone Number: 02 47 47 97 47
- Email: claire.wardak@univ-tours.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Social security affiliation
- Free and written informed consent from the participants (Neurotypical Adults, NDD Adults without judicial protective measures), or their tutor or legal representant(s) (other participants)
- Age between 6 and 12 years included (Children) or between 18 and 45 years included (Adults)
- For NDD participants: NDD diagnosis by a qualified medical professional, according to DSM-4, DSM-5, ICD-10 or ICD-11 criteria
Non-inclusion Criteria:
- Psychotropic medication perturbing EEG recording
- Drugs pertubing peripheral neurophysiological measures
- Non-corrected visual or auditory troubles
- Known neurological or psychiatric conditions (at the exclusion of NDD for NDD participants)
- Epilepsy
- Inclusion in another ongoing medical protocol
- For Neurotypical participants: NDD diagnosis
- For NDD participants: anticipated psychological or physical risk at participating, at the investigator's discretion
Exclusion Criteria:
- Participants with no data to evaluate Outcome 1
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Neurodevelopmental Disorders Children
6-12 years old children
|
|
Neurodevelopmental Disorders Adults
18-45 years old adults
|
|
Neurotypical Children
6-12 years old children
|
|
Neurotypical Adults
18-45 years old adults
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amplitude of central neurophysiological responses to sensory stimulations
Time Frame: Through study completion, an average of 2 months per participant
|
Amplitude (in micro-volts) of event-related potentials
|
Through study completion, an average of 2 months per participant
|
|
Latency of central neurophysiological responses to sensory stimulations
Time Frame: Through study completion, an average of 2 months per participant
|
Latency (in milli-seconds) of event-related potentials
|
Through study completion, an average of 2 months per participant
|
|
Variability of central neurophysiological responses to sensory stimulations
Time Frame: Through study completion, an average of 2 months per participant
|
Intra-individual variability (in percentage) of event-related potentials
|
Through study completion, an average of 2 months per participant
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual perceptual learning performance
Time Frame: Through study completion, an average of 2 months per participant
|
Discrimination performance (in percentage) for visual delayed-matching to sample task
|
Through study completion, an average of 2 months per participant
|
|
Auditory perceptual learning performance
Time Frame: Through study completion, an average of 2 months per participant
|
Discrimination performance (in percentage) for auditory delayed-matching to sample task
|
Through study completion, an average of 2 months per participant
|
|
Behavioral sensory profile
Time Frame: Through study completion, an average of 2 months per participant
|
Score (in absolute score) for psychomotor evaluation (Échelle des Particularités Sensori-psychomotrices dans l'Autisme)
|
Through study completion, an average of 2 months per participant
|
|
Sensory profile questionnaire
Time Frame: Through study completion, an average of 2 months per participant
|
Score (in absolute score) for sensory questionnaire (Dunn Sensory Profile)
|
Through study completion, an average of 2 months per participant
|
|
Cognitive psychological profile
Time Frame: Through study completion, an average of 2 months per participant
|
Score (in absolute score) for cognitive test (Raven's Progressive Matrices)
|
Through study completion, an average of 2 months per participant
|
|
Executive functions questionnaire
Time Frame: Through study completion, an average of 2 months per participant
|
Score (in absolute score) for executive functions questionnaire (BRIEF or BRIEF-A depending on the group)
|
Through study completion, an average of 2 months per participant
|
|
Attentional functions questionnaire
Time Frame: Through study completion, an average of 2 months per participant
|
Score (in absolute score) for attentional functions questionnaire (SNAP-IV-26 or ASRS-V1.1 depending on the group)
|
Through study completion, an average of 2 months per participant
|
|
Socio-emotional questionnaire
Time Frame: Through study completion, an average of 2 months per participant
|
Score (in absolute score) for socio-emotional questionnaire (AQ)
|
Through study completion, an average of 2 months per participant
|
|
Linguistic profile
Time Frame: Through study completion, an average of 2 months per participant
|
Score (in absolute score) for non-words and sentences repetition (LITMUS)
|
Through study completion, an average of 2 months per participant
|
|
Heart beat response to sensory stimulations
Time Frame: Through study completion, an average of 2 months per participant
|
Heart beat variation (in milliseconds) following sensory stimulation, recorded simultaneously with EEG
|
Through study completion, an average of 2 months per participant
|
|
Electrodermal activity response to sensory stimulations
Time Frame: Through study completion, an average of 2 months per participant
|
Electrodermal activity variation (in microsiemens) following sensory stimulation, recorded simultaneously with EEG
|
Through study completion, an average of 2 months per participant
|
|
Pupillary response to sensory stimulations
Time Frame: Through study completion, an average of 2 months per participant
|
Pupillary diameter variation (in millimeter) following sensory stimulation,recorded simultaneously with EEG
|
Through study completion, an average of 2 months per participant
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DR240270
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurodevelopmental Disorders
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Fondation Perce NeigeNot yet recruitingNeurodevelopmental Disorders With Severe Self-injuriesFrance
-
University of SevilleRecruitingNeurodevelopmental Disorders | Neurodevelopmental Disorders and Developmental AbnormalitiesSpain
-
University Hospital, Clermont-FerrandNot yet recruitingNeurodevelopmental Disorder (Diagnosis)France
-
University of Missouri-ColumbiaCompletedChildren With Neurodevelopmental DisordersUnited States
-
IRCCS Eugenio MedeaRecruitingNeurodevelopmental Disorder (Diagnosis)Italy
-
Haute Ecole Ilya PrigogineNot yet recruitingNeurodevelopmental Disorders
-
IRCCS Centro Neurolesi Bonino PulejoRecruitingNeurodevelopmental DisordersItaly
-
Aiyoudong Children and Youth Sports Health Research...Not yet recruitingNeurodevelopmental DisordersChina
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingFetal Neurodevelopmental Disorder | Cavum Septum PellucidumItaly
-
IRCCS Eugenio MedeaRecruitingNeurodevelopmental Disorder (Diagnosis)Italy